|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| A61K 31/517 | (2013.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/7068 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/4709 | (2013.01) | ||
| A61K 31/496 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3175853 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16203986.1 |
| Date of filing the European patent application | 2009-08-04 | |
| (97) | Date of publication of the European application | 2017-06-07 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 85913 P | 2008-08-04 | US | |
| 172466 P | 2009-04-24 | US |
| (72) |
WANG, Kenneth , US
ZACHARCHUK, Charles , US
BINLICH, Florence , FR
QUINN, Susan , US
|
| (73) |
Wyeth LLC ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (54) | ANTINEOPLASTIC COMBINATIONS OF NERATINIB AND CAPECITABINE |
| ANTINEOPLASTIC COMBINATIONS OF NERATINIB AND CAPECITABINE |